By Janet Fang Short sequences of RNA that can effectively turn off specific genes have for the first time been used to treat skin cancer in people. The technique, called RNA interference (RNAi), gained its inventors a Nobel Prize in 2006, but researchers have struggled to get it to the clinic, partly because of problems in getting the molecules to their target. Now, Mark Davis from the ...